Breast tumors are traditionally classified into distinct molecular groups based on their estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression patterns [5–7]. This evidence concerns the gene ESR1 and breast neoplasm.